Quantum MRI agents for assessing early patient response to treatment at the metabolic level
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Ulm
State: Baden-Wurttemberg
Zip:
Country: Germany
NVision has developed a platform which polarizes natural metabolites, enabling these safe molecules to be used as an agent for imaging tumor metabolism via MRI. This technology will allow clinicians to quickly determine which patients are responding to cancer therapies, allowing non-responders to be moved onto another line of therapy more quickly. The company was founded in 2015 and is based in Ulm, Germany.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|